Ketamine Induces Ferroptosis of Liver Cancer Cells by Targeting lncRNA PVT1/miR-214-3p/GPX4
Guan-Nan He,Na-Ren Bao,Shuang Wang,Man Xi,Tian-Hao Zhang,Feng-Shou Chen
DOI: https://doi.org/10.2147/DDDT.S332847
2021-09-18
Abstract:Guan-Nan He, Na-Ren Bao, Shuang Wang, Man Xi, Tian-Hao Zhang, Feng-Shou Chen Department of Anesthesiology, First Affiliated Hospital, China Medical University, Shenyang, 110001, Liaoning, People's Republic of China Correspondence: Feng-Shou Chen Department of Anesthesiology, First Affiliated Hospital, China Medical University, Shenyang, 110001, Liaoning, People's Republic of China Email Background: Liver cancer ranks the top four malignant cancer type worldwide, which needs effective and safe treatment. Ferroptosis is a novel form of regulated cell death driven by iron-dependent lipid peroxidation and has been regarded as a promising therapeutic target for cancers. In this work, we aimed to study the effects of anesthetic ketamine on proliferation and ferroptosis of liver cancer. Methods: Cell viability and proliferation were detected by cell counting kit 8 (CCK-8), colony formation, and 5-ethynyl-2′-deoxyuridine (EdU) assay. Ferroptosis was determined by levels of Fe 2+ , lipid reactive oxygen species (ROS), and malondialdehyde (MDA). RNA levels of lncPVT1, miR-214-3p, and glutathione peroxidase 4 (GPX4) were checked by real-time PCR assay. Clinical liver tumor samples were collected to detect the levels of long noncoding RNA lncPVT1, miR-214-3p, and GPX4, and their correlation was evaluated by Pearson comparison test. Luciferase reporter gene assay and RNA pulldown were conducted to determine the binding between lncPVT1, miR-214-3p, and GPX4 3ʹUTR. Results: Ketamine significantly suppressed viability and proliferation of liver cancer cells both in vitro and in vivo, as well as stimulated ferroptosis, along with decreased expression of lncPVT1 and GPX4. LncPVT1 directly interacted with miR-214-3p to impede its role as a sponge of GPX4. Depletion of lncPVT1 accelerated the ferroptosis of live cancer cells, whereas miR-214-3p inhibition and GPX4 overexpression reversed this effect. Ketamine-induced cell growth suppression and ferroptosis were also suppressed by miR-214-3p inhibition and GPX4 overexpression. Conclusion: In this work, we determined that ketamine suppressed viability of liver cancer cells and induced ferroptosis and identified the possible regulatory mechanism of lncPVT1/miR-214-3p/GPX4 axis. Keywords: liver cancer, ketamine, lncPVT1, miR-214-3p, GPX4 Liver cancer ranks the top four malignant cancer type worldwide, among which hepatocellular carcinoma (HCC) is the mostly frequently occurred form. 1 Most liver cancer cases are diagnosed at late stages due to the delayed symptoms and aggressive growth, 2 which leads to less than ten months median survival and a 5-year overall survival rate of 10% of patients diagnosed with advanced liver cancer. 3 Liver cancer is commonly generated from alcohol, non-alcoholic fatty liver disease (NAFLD), cirrhosis, and virus infection including hepatitis B virus (HBV) and hepatitis C virus (HCV). 4 Surgical resection of tumors is currently the predominant treatment for liver cancer, and the multi-kinase inhibitor sorafenib is the only first-line drug. 4 Hence, it is urgent to explore novel treatments for liver cancer. Ferroptosis is a novel form of regulated cell death driven by iron-dependent lipid peroxidation, featured by increased free iron and accumulated lipid peroxides, which leads to accumulated intracellular reactive oxygen species (ROS) production and subsequent oxidative cell death. 5,6 The phospholipid glutathione peroxidase 4 (GPX4) is an antioxidant that catalyzes the reduction of peroxide such as hydrogen peroxide and organic hydroperoxides, through co-acting with antioxidant glutathione (GSH). 7 Accumulating evidences have demonstrated the critical inhibitory function of GPX4 during ferroptosis. 7 Moreover, several small molecules, including Erastin and RSL3, have been recognized as inducers of ferroptosis, via suppressing the activity of GPX4. 8,9 Ketamine is a commercially used rapid-acting anesthetic agent since 1970. 10 Despite the risk of dissociative effects and abuse potential, ketamine is a desirable drug owing to its short half-life and lack of clinically significant respiratory depression. 11–15 In addition to the anesthetic effect, accumulating researches have proved that ketamine exhibits anti-inflammatory activity, analgesic effect, and antidepressant effect. 16–19 Although ketamine has been widely suggested as an adjunctive agent to deal with cancer-related pain, 20–22 its effects on cancer therapy and the mechanisms are largely unknown. Long noncoding RNAs (lncRNAs) are defined as a class of RNAs with a sequence longer than 200 nucleotides. 23 Numerous studies have revealed the anticancer eff -Abstract Truncated-